inhibition studies with muscarinic receptor subtype-specific antagonists suggest that norepinephrine release is regulated by an m2 subtype muscarinic receptor and that phosphoinositide hydrolysis is regulated by an m3 subtype muscarinic receptor .
C0034826
muscarinic receptor
C0384752
m2